Novartis confirmed that brothers Brian Kaspar and Allan Kaspar, who ran a gene-therapy subsidiary at the drugmaker accused by federal regulators of manipulating data, are no longer with the company. The Food and Drug Administration said the Swiss drugmaker could face criminal or civil penalties for allegedly providing inaccurate data […]